Insider Bets and Options Frenzy Fuel UnitedHealth (UNH) Bull Run

Wall Street's latest darling? UnitedHealth (UNH) just got a double-shot of adrenaline—insiders are loading up, and options traders are piling in like it's a Black Friday crypto flash crash.

Smart money moves: When execs buy and derivatives explode, someone knows something. Or at least they think they do—never underestimate herd mentality in a market that still runs on Excel spreadsheets.

The big question: Is this sustainable momentum or just another institutional pump before the quarterly earnings dump? Either way, the suits are placing their bets.

Confident Investing Starts Here:

• Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
• Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter

Heightened Activity Signals Bullish Sentiment

On Thursday, more than 162,000 call options were traded on UNH. That’s a 29% jump compared to the stock’s typical daily call volume of around 126,000. This level of activity often reflects bullish expectations from traders anticipating upward price movement.

Insiders are also showing conviction. Director John H. Noseworthy purchased 300 shares at an average price of $312.16. More significantly, CEO Stephen Hemsley bought 86,700 shares at an average of $288.57 per share, totaling over $25 million. In total, insiders have acquired 109,408 shares over the past 90 days, worth approximately $31.6 million. Insider buying of this scale often signals confidence in long-term value.

Institutional investors have also been increasing their exposure to these assets. Vanguard, Wellington Management, and Norges Bank all added to their positions last quarter. Institutional ownership now stands at 87.9%, highlighting continued support from long-term holders.

Stock Rebounds Slightly as Fundamentals Show Mixed Signals

The stock closed Friday at $303.22, up 2.49% on the day. It remains far below its 52-week high of $630.73 and just above the recent low of $248.88. At current levels, UNH has a market cap of about $275 billion, a P/E ratio of 14.11, and a dividend yield of 2.84%. The company recently raised its quarterly dividend to $2.21 per share.

UnitedHealth posted Q1 revenue of $109.6 billion, slightly below consensus estimates. Earnings per share came in at $7.20, missing expectations of $7.29. While analysts still expect full-year EPS of $29.54, several firms have lowered their price targets in response to the softer results and rising sector concerns.

Options market data reinforces the bullish tilt. The put/call ratio is 0.48, indicating more call buying than put buying. This ratio suggests traders are positioning for a potential rebound in the NEAR term.

In summary, while UnitedHealth continues to face pressure from weaker earnings and macroeconomic headwinds, the surge in call option activity, insider buying, and strong institutional support indicate renewed investor interest.

Is UNH a Good Stock to Buy Right Now?

According to The Street’s analysts, UnitedHealth is a Moderate Buy. The average UNH price target is $369.73, implying a 21.93% upside.